Russell Alan J 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Russell Alan J（CIK 1853529）在 1 家公司共报告 17 笔 SEC Form 4 内部人交易（最近一笔 2026-08-14）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | 买入 | 5,781 | $0 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | 买入 | 7,031 | $0 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | 卖出 | 3,238 | $141,428 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | 卖出 | 2,273 | $99,275 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | 卖出 | 390 | $17,339 |
| 2026-07-02 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | 买入 | 130,352 | $58,658 |
| 2026-07-02 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | 买入 | 69,648 | $12,537 |
| 2026-07-02 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | 卖出 | 130,352 | $5.1M |
| 2026-07-02 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | 卖出 | 69,648 | $2.7M |
| 2025-11-13 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | 买入 | 100,000 | $18,000 |
| 2025-11-13 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | 卖出 | 100,000 | $2.1M |
| 2025-08-28 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | 买入 | 100,000 | $18,000 |
| 2025-08-28 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | 卖出 | 100,000 | $1.5M |
| 2025-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | 买入 | 5,781 | $0 |
| 2025-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | 卖出 | 1,907 | $25,535 |
| 2025-05-07 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | 买入 | 5,209 | $0 |
| 2025-05-07 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | 卖出 | 1,551 | $25,514 |
来源：SEC Form 4 申报文件 · 截至 2026-08-14